Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 466694017 | Topotecan 4mg i-v infusion (pdr for recon) | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 719330013 | Topotecan 4mg i-v infusion (pdr for recon) (substance) | en | Fully specified name | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 1191303012 | Topotecan 4mg i-v infusion (pdr for recon) (product) | en | Fully specified name | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 1457172012 | Topotecan 4mg powder for infusion solution vial (product) | en | Fully specified name | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 1477700012 | Topotecan 4mg powder for infusion solution vial | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3690062012 | Product containing precisely topotecan (as topotecan hydrochloride) 4 milligram/1 vial powder for conventional release solution for injection | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3690063019 | Topotecan (as topotecan hydrochloride) 4 mg powder for solution for injection vial | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3690064013 | Product containing precisely topotecan (as topotecan hydrochloride) 4 milligram/1 vial powder for conventional release solution for injection (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Topotecan (as topotecan hydrochloride) 4 mg powder for solution for injection vial | Is a | Product containing topotecan (medicinal product) | false | Inferred relationship | Some | ||
| Topotecan (as topotecan hydrochloride) 4 mg powder for solution for injection vial | Has active ingredient | Topotecan (substance) | false | Inferred relationship | Some | ||
| Topotecan (as topotecan hydrochloride) 4 mg powder for solution for injection vial | Has manufactured dose form | Injection | false | Inferred relationship | Some | ||
| Topotecan (as topotecan hydrochloride) 4 mg powder for solution for injection vial | Is a | Product containing topotecan in parenteral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Topotecan (as topotecan hydrochloride) 4 mg powder for solution for injection vial | Has manufactured dose form | Powder for infusion solution | false | Inferred relationship | Some | ||
| Topotecan (as topotecan hydrochloride) 4 mg powder for solution for injection vial | Has basis of strength substance (attribute) | Topotecan (substance) | true | Inferred relationship | Some | 1 | |
| Topotecan (as topotecan hydrochloride) 4 mg powder for solution for injection vial | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Topotecan (as topotecan hydrochloride) 4 mg powder for solution for injection vial | Has unit of presentation | Vial (unit of presentation) | true | Inferred relationship | Some | ||
| Topotecan (as topotecan hydrochloride) 4 mg powder for solution for injection vial | Count of base of active ingredient | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | ||
| Topotecan (as topotecan hydrochloride) 4 mg powder for solution for injection vial | Has presentation strength denominator value | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | 1 | |
| Topotecan (as topotecan hydrochloride) 4 mg powder for solution for injection vial | Has presentation strength denominator unit (attribute) | Vial (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Topotecan (as topotecan hydrochloride) 4 mg powder for solution for injection vial | Has precise active ingredient | Topotecan hydrochloride | true | Inferred relationship | Some | 1 | |
| Topotecan (as topotecan hydrochloride) 4 mg powder for solution for injection vial | Has presentation strength numerator value | 4 (kwalificatiewaarde) | false | Inferred relationship | Some | 1 | |
| Topotecan (as topotecan hydrochloride) 4 mg powder for solution for injection vial | Has manufactured dose form | Powder for solution for injection | true | Inferred relationship | Some | ||
| Topotecan (as topotecan hydrochloride) 4 mg powder for solution for injection vial | Is a | Product containing only topotecan in parenteral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Topotecan (as topotecan hydrochloride) 4 mg powder for solution for injection vial | Plays role | Antineoplastic therapeutic role | false | Inferred relationship | Some | ||
| Topotecan (as topotecan hydrochloride) 4 mg powder for solution for injection vial | Is a | Product containing precisely topotecan (as topotecan hydrochloride) 4 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR